Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
adsorbed acellular DTP-IPV combined vaccine
- Development stage
- Unknown
- Lead developer
- Shenzhen Kangtai Biological Products
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
The adsorbed acellular DTP-IPV combined vaccine is a quadrivalent combination vaccine developed by Kangtai Biological (Minhai Biotechnology) for the active immunization of infants and children against diphtheria, tetanus, pertussis, and poliomyelitis. The vaccine consists of diphtheria toxoid, tetanus toxoid, acellular pertussis antigens, and inactivated poliovirus (IPV) types 1, 2, and 3, adsorbed onto an aluminum-based adjuvant. By combining these antigens into a single injection, the vaccine aims to reduce the number of required immunizations, thereby improving compliance and coverage. It is currently undergoing Phase 1 clinical trials in China.
- Other names
- DTaP-IPV vaccineDTP-IPV vaccineadsorbed acellular pertussis, diphtheria, tetanus and poliomyelitis (inactivated) vaccine
02
Targets
Diphtheria toxin
Beyond the preview
Go deeper on adsorbed acellular DTP-IPV combined vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on adsorbed acellular DTP-IPV combined vaccine.